News and Announcements
Altech Raises $10 Million in Oversubscribed Share Placement
- Published July 27, 2016 1:43PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
27th July 2016, ASX Announcement
Highlights:
- $10 million raised via share placement to institutions, professional and sophisticated investors
- Placement was heavily oversubscribed
- A range of quality institutional investors join Altech’s share register
Altech Chemicals Limited (Altech/the Company) (ASX: ATC) has welcomed a number of institutional investors onto its share register as a result of a $10 million oversubscribed share placement (the Placement). Placement shares will be issued at 14 cents per share, which represents a 14% discount to the price of the Company’s shares at the close of trade on the Australian Securities Exchange (ASX) on 21 July 2016.
Funds raised from the Placement will be applied to finalising the detailed design of the Company’s proposed Malaysian high purity alumina (HPA) plant, completion of independent due diligence associated with finalising debt financing, closure of debt financing and general working capital purposes.
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
